首頁 > 市場調查報告書 > 製藥

疫苗動物用醫藥

獸用疫苗市場規模、佔有率和成長分析（按類型、疾病、技術、給藥途徑、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1897335

獸用疫苗市場規模、佔有率和成長分析（按類型、疾病、技術、給藥途徑、最終用戶和地區分類）—產業預測（2026-2033 年）

Veterinary Vaccines Market Size, Share, and Growth Analysis, By Type, By Disease, By Technology, By Route Of Administration, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球獸用疫苗市場規模將達到 92.1 億美元，到 2025 年將達到 98.6 億美元，到 2033 年將達到 170.8 億美元，預測期（2026-2033 年）的複合年成長率為 7.1%。

全球獸用疫苗市場正經歷快速成長，主要驅動力在於人們對動物健康的日益關注以及對肉類、牛奶和雞蛋等動物性產品需求的不斷成長。通用感染疾病率的上升凸顯了預防措施和食品安全永續性的必要性。此外，牲畜數量的成長和對食品安全的日益重視也推動了市場需求。疫苗研發的創新提高了疫苗的有效性和安全性，使其越來越受到獸醫和寵物飼主的認可。主要市場參與者對研發的大量投入，以及各國政府為防治動物疾病（尤其是在新興市場）所採取的舉措，都為市場成長提供了強而有力的支持。動物疾病的日益普及正在推動疫苗的普及，尤其是在家禽和反芻動物領域。

全球獸用疫苗市場促進因素

全球獸用疫苗市場的主要驅動力是通用傳染病的日益普及。人畜共通傳染病是指可以從動物感染疾病。狂犬病、禽流感和豬流感等疾病的爆發推動了對有效獸用疫苗的需求。為動物接種疫苗可以降低疾病傳播給人類的風險，有助於遏制潛在的疾病爆發並改善公共衛生。此外，全球人口的成長和飲食習慣的改變，尤其是在開發中國家，導致動物性蛋白質的消費量增加，進一步推動了獸用疫苗的需求。

全球獸用疫苗市場面臨的限制因素

全球獸用疫苗市場面臨許多挑戰，這主要歸因於疫苗研發的複雜性和漫長過程，其中涉及廣泛的研究、臨床試驗和法規核准流程。疫苗研發和生產的高昂成本可能令許多農民和寵物飼主望而卻步，尤其是在資源匱乏的地區。此外，在符合要求的條件下妥善儲存和運輸疫苗也需要額外費用，這進一步增加了總成本。這些經濟障礙可能會阻礙獸用疫苗的廣泛應用，尤其是在資源有限的發展中地區，最終阻礙市場成長。

全球獸用疫苗市場趨勢

全球獸用疫苗市場的一個顯著趨勢是重組疫苗的日益普及，這主要得益於生物技術的進步。這些創新疫苗能夠精準標靶化病原體，顯著提高對伴侶動物和家畜的療效和保護作用。此外，這些疫苗的混合特性最大限度地減少了副作用，從而贏得了獸醫和寵物飼主的信任和認可。這種向更有效、更安全的疫苗選擇的轉變，反映了人們對改善動物健康的廣泛關注，也與消費者對高品質獸醫服務的需求不斷成長不謀而合。因此，疫苗市場正經歷強勁的成長和產品種類的多樣化。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Zoetis, Inc.（US）
Merck & Co, Inc.（US）
Boehringer Ingelheim International GmbH（Germany）
Elanco Animal Health（US）
Virbac（France）
Hester Biosciences Limited（India）
Neogen Corporation（US）
HIPRA（Spain）
Biogenesis Bago（Argentina）
Tianjin Ringpu Bio-Technology Co Ltd.（China）
China Animal Husbandry Group（China）
Jinyu Bio-technology（China）
Vaxxinova International BV（Netherlands）
Endovac Animal Health（US）
Brilliant Bio Pharma（India）
Aptimmune（US）
Indian Immunologicals Ltd.（India）
Torigen Pharmaceuticals, Inc.（US）
VEROVACCiNES GmbH（Germany）
Intas Pharmaceuticals（India）
Ourofino Animal Health（Brazil）
Biovac（Israel）
Laboratoire LCV（France）

結論與建議

簡介目錄

Product Code: SQMIG35I2239

Global Veterinary Vaccines Market size was valued at USD 9.21 Billion in 2024 and is poised to grow from USD 9.86 Billion in 2025 to USD 17.08 Billion by 2033, growing at a CAGR of 7.1% during the forecast period (2026-2033).

The global veterinary vaccines market is experiencing rapid growth, largely fueled by heightened awareness of animal health and the rising demand for animal-derived products like meat, milk, and eggs. The escalating incidence of zoonotic diseases underscores the necessity for preventive measures and food security sustainability. Additionally, the expanding livestock population and a stronger emphasis on food safety bolster market demand. Innovations in vaccine development, promoting improved efficacy and safety, are becoming increasingly favored by veterinarians and pet owners alike. Significant investments from leading market players in research and development, paired with government initiatives aimed at combating animal diseases, particularly in emerging markets, are providing crucial support for market growth. The rising prevalence of animal diseases drives the adoption of vaccines, especially in poultry and ruminants.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Vaccines Market Segments Analysis

Global Veterinary Vaccines Market is segmented by Type, Disease, Technology, Route Of Administration, End User and region. Based on Type, the market is segmented into Livestock Vaccines, Porcine Vaccines, Poultry Vaccines, Companion Animal Vaccines, Aquaculture Vaccines and Other Veterinary Vaccines. Based on Disease, the market is segmented into Livestock Diseases, Porcine Diseases,Poultry Diseases, Companion Animal Diseases, Aquaculture Diseases and Other Veterinary Diseases. Based on Technology, the market is segmented into Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines and Other Vaccine Technologies. Based on Route Of Administration, the market is segmented into Subcutaneous Route of Administration, Intramuscular Route of Administration, Oral Route of Administration, Intranasal/Spray Route of Administration, Intraocular Route of Administration and Other Routes of Administration. Based on End User, the market is segmented into Veterinary Hospitals, Veterinary Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Vaccines Market

The Global Veterinary Vaccines market is significantly driven by the rising prevalence of zoonotic diseases, which are infectious illnesses that can be transmitted from animals to humans. Outbreaks of diseases such as rabies, avian influenza, and swine flu have heightened the need for effective veterinary vaccinations. By immunizing animals against these diseases, the risk of transmission to humans diminishes, which in turn helps mitigate potential disease outbreaks and enhances public health. Additionally, the growing global population and shifting dietary preferences, particularly in developing nations, have led to an increased consumption of animal protein, further intensifying the demand for veterinary vaccines.

Restraints in the Global Veterinary Vaccines Market

The global veterinary vaccines market faces significant challenges due to the intricacies and lengthy nature of vaccine development, which encompasses extensive research, clinical trials, and regulatory processes. The substantial costs associated with developing and manufacturing vaccines can render them unaffordable for many farmers and pet owners, particularly in under-resourced areas. Additionally, the expenses related to proper storage and transportation of vaccines under required conditions further elevate overall costs. These financial barriers can hinder the widespread adoption of veterinary vaccines, ultimately stifling market growth, especially in developing regions where resources are constrained.

Market Trends of the Global Veterinary Vaccines Market

A notable trend in the global veterinary vaccines market is the rising adoption of recombinant vaccines, driven by advancements in biotechnology. These innovative vaccines leverage precise targeting of pathogens, significantly enhancing efficacy and protection for both companion animals and livestock. Additionally, the hybrid nature of these vaccines minimizes adverse reactions, fostering increased trust and acceptance among veterinarians and pet owners alike. This shift towards more effective and safer vaccination options reflects a broader focus on improving animal health outcomes and aligns with growing consumer demand for high-quality veterinary care. As a result, the market is witnessing robust growth and diversification in vaccine offerings.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Supply Chain Analysis
Trade Analysis
Patent Analysis
Technology Analysis
Case Studies
Customer And Buying Criteria Analysis

Global Veterinary Vaccines Market Size by Type & CAGR (2026-2033)

Market Overview
Livestock Vaccines
- Bovine Vaccines
- Small Ruminant Vaccines
Porcine Vaccines
Poultry Vaccines
Companion Animal Vaccines
- Canine Vaccines
- Feline Vaccines
Aquaculture Vaccines
Other Veterinary Vaccines

Global Veterinary Vaccines Market Size by Disease & CAGR (2026-2033)

Market Overview
Livestock Diseases
- Bovine Diseases
- Small Ruminant Diseases
Porcine Diseases
Poultry Diseases
Companion Animal Diseases
- Canine Diseases
- Feline Diseases
Aquaculture Diseases
Other Veterinary Diseases

Global Veterinary Vaccines Market Size by Technology & CAGR (2026-2033)

Market Overview
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccine Technologies

Global Veterinary Vaccines Market Size by Route Of Administration & CAGR (2026-2033)

Market Overview
Subcutaneous Route of Administration
Intramuscular Route of Administration
Oral Route of Administration
Intranasal/Spray Route of Administration
Intraocular Route of Administration
Other Routes of Administration

Global Veterinary Vaccines Market Size by End User & CAGR (2026-2033)

Market Overview
Veterinary Hospitals
Veterinary Clinics
Other End Users

Global Veterinary Vaccines Market Size & CAGR (2026-2033)

North America (Type, Disease, Technology, Route Of Administration, End User)
- US
- Canada
Europe (Type, Disease, Technology, Route Of Administration, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Disease, Technology, Route Of Administration, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Disease, Technology, Route Of Administration, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Disease, Technology, Route Of Administration, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Zoetis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hester Biosciences Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HIPRA (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogenesis Bago (Argentina)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tianjin Ringpu Bio-Technology Co Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
China Animal Husbandry Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jinyu Bio-technology (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vaxxinova International BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endovac Animal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brilliant Bio Pharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptimmune (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indian Immunologicals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Torigen Pharmaceuticals, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VEROVACCiNES GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intas Pharmaceuticals (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ourofino Animal Health (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biovac (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratoire LCV (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments